How Brooklyn Health aims to modernize mental health assessment in clinical trials
Neuroscience technology company Brooklyn Health is using artificial intelligence to target a fundamental problem in neurology and psychiatry: the flawed approach to mental health outcomes measureme | Brooklyn Health aims to modernize mental health measurement and scoring in central nervous system drug development. The startup’s platform uses AI and digital phenotyping methods it developed to evaluate the quality and scoring of clinical interviews in real time.
